Showing results (1791-1800 of 1,810) with videos related to

Sort By:
Pageof 181
Frontiers in Oncology|March 3, 2023
Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinomaJing Feng Hu, Xin Song, Kan Zhong, et al.
Science Advances|April 17, 2024
Optical control of 4f orbital state in rare-earth metalsNele Thielemann-Kühn, Tim Amrhein, Wibke Bronsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority TrialXiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.
Frontiers in Oncology|March 6, 2023
Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in ChinaLing-Ling Lei, Xin Song, Xue-Ke Zhao, et al.
JAMA Oncology|June 18, 2025
Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical TrialShan-Shan Guo, Xiao-Yun Li, Li-Ting Liu, et al.
Nature Communications|March 31, 2026
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trialLi-Ting Liu, Xue-Song Sun, Ting-Ting Quan, et al.
The Lancet. Oncology|June 8, 2023
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trialLi-Ting Liu, Huai Liu, Ying Huang, et al.
The Lancet. Oncology|November 10, 2024
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trialSai-Lan Liu, Xiao-Yun Li, Jin-Hao Yang, et al.
Hepatology International|June 21, 2022
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching studyKe Su, Tao Gu, Ke Xu, et al.
Hepatology International|August 16, 2022
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter studyKe Su, Yanlin Liu, Pan Wang, et al.
Pageof 181